Scott Terrillion - 21 Dec 2022 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
Sec'y; Chief Compliance & G.C.
Signature
/s/ Darren DeStefano, Attorney-in-Fact
Issuer symbol
CARA
Transactions as of
21 Dec 2022
Net transactions value
-$28,862
Form type
4
Filing time
23 Dec 2022, 15:52:37 UTC
Previous filing
05 Apr 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale $28,862 -2,561 -2.5% $11.27* 99,783 21 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on December 21, 2021, and does not represent a discretionary trade by the Reporting Person.